130 related articles for article (PubMed ID: 6496322)
1. Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension.
Papademetriou V; Price M; Johnson E; Smith M; Freis ED
Am J Cardiol; 1984 Nov; 54(8):1015-9. PubMed ID: 6496322
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of potassium chloride or triamterene in thiazide hypokalemia.
Papademetriou V; Burris J; Kukich S; Freis ED
Arch Intern Med; 1985 Nov; 145(11):1986-90. PubMed ID: 3904654
[TBL] [Abstract][Full Text] [Related]
3. Diuretic-induced hypokalemia in uncomplicated systemic hypertension: effect of plasma potassium correction on cardiac arrhythmias.
Papademetriou V; Fletcher R; Khatri IM; Freis ED
Am J Cardiol; 1983 Nov; 52(8):1017-22. PubMed ID: 6195908
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
[TBL] [Abstract][Full Text] [Related]
5. Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide.
Schnaper HW; Freis ED; Friedman RG; Garland WT; Hall WD; Hollifield J; Jain AK; Jenkins P; Marks A; McMahon FG
Arch Intern Med; 1989 Dec; 149(12):2677-81. PubMed ID: 2596940
[TBL] [Abstract][Full Text] [Related]
6. Diuretic regimens in essential hypertension. A comparison of hypokalemic effects, BP control, and cost.
Licht JH; Haley RJ; Pugh B; Lewis SB
Arch Intern Med; 1983 Sep; 143(9):1694-9. PubMed ID: 6412642
[TBL] [Abstract][Full Text] [Related]
7. The effect of triamterene on plasma and extracellular fluid volume and blood pressure in ten thiazide-treated hypokalemic patients with essential hypertension.
Leth A; Ibsen H; Sederberg-Olsen P
Scand J Clin Lab Invest; 1972 Dec; 30(4):437-40. PubMed ID: 4639649
[No Abstract] [Full Text] [Related]
8. Hypokalemia in thiazide-treated systemic hypertension.
Maronde RF; Chan LS; Vlachakis N
Am J Cardiol; 1986 Jul; 58(2):18A-21A. PubMed ID: 3524185
[TBL] [Abstract][Full Text] [Related]
9. Oral potassium chloride and amiloride in hydrochlorothiazide-induced potassium loss.
Maronde RF; Barr J; Vlachakis ND; Spencer CA; Chan L
Clin Pharmacol Ther; 1984 Oct; 36(4):431-5. PubMed ID: 6478730
[TBL] [Abstract][Full Text] [Related]
10. Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide).
Hollenberg NK; Mickiewicz CW
Am J Cardiol; 1989 Jan; 63(4):37B-41B. PubMed ID: 2911994
[TBL] [Abstract][Full Text] [Related]
11. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of diuretic-induced hypopotassemia in human hypertension.
Kezdi P; Danopulos D; Stanley EL; Mullins M
Klin Wochenschr; 1985; 63 Suppl 3():125-8. PubMed ID: 2987608
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two combined diuretics in the treatment of essential hypertension.
Verhiest W; Baehre M; Volkers P
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
[TBL] [Abstract][Full Text] [Related]
14. Hypokalemia during the treatment of arterial hypertension with diuretics.
Lemieux G; Beauchemin M; Vinay P; Gougoux A
Can Med Assoc J; 1980 Apr; 122(8):905-7. PubMed ID: 7370875
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cardiac arrhythmias associated with mild hypokalemia induced by low-dose diuretic therapy for hypertension.
Peters RW; Hamilton J; Hamilton BP
South Med J; 1989 Aug; 82(8):966-9, 976. PubMed ID: 2669155
[TBL] [Abstract][Full Text] [Related]
16. Outpatient conversion of treatment to potassium-sparing diuretics.
Ridgeway NA; Ginn DR; Alley K
Am J Med; 1986 May; 80(5):785-8. PubMed ID: 3706365
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
Williams RL; Clark T; Blume CD
Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene.
Kohvakka A
Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):273-7. PubMed ID: 3045028
[TBL] [Abstract][Full Text] [Related]
19. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide.
Plante GE; Dessurault DL
Am J Med; 1988 Jan; 84(1B):98-103. PubMed ID: 3341391
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
Smith SM; Anderson SD; Wen S; Gong Y; Turner ST; Cooper-Dehoff RM; Schwartz GL; Bailey K; Chapman A; Hall KL; Feng H; Boerwinkle E; Johnson JA; Gums JG
Pharmacotherapy; 2009 Oct; 29(10):1157-65. PubMed ID: 19792989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
